Table 2 The frequency of comorbidity and neurological manifestations in patients with COVID-19
Comorbidity | Frequency | Percent | Valid Percent |
|---|---|---|---|
No comorbidity | 26 | 37.1 | 37.1 |
Single comorbidity | |||
HTN | 11 | 15.7 | 15.7 |
SLE | 4 | 5.7 | 5.7 |
DM | 4 | 5.7 | 5.7 |
Cardiac | 4 | 5.7 | 5.7 |
CKD | 3 | 4.3 | 4.3 |
Morbid obesity | 3 | 4.3 | 4.3 |
Rheumatoid arthritis | 1 | 1.4 | 1.4 |
Lymphoma | 1 | 1.4 | 1.4 |
Multiple comorbidity | |||
DM and HTN | 4 | 5.7 | 5.7 |
Obesity and DM | 3 | 4.3 | 4.3 |
Cardiac and HTN | 1 | 1.4 | 1.4 |
Obesity and HTN | 1 | 1.4 | 1.4 |
Lymphoma and HTN | 1 | 1.4 | 1.4 |
Obesity, HTN, Cardiac | 1 | 1.4 | 1.4 |
SLE, DM, HTN | 1 | 1.4 | 1.4 |
Total | 70 | 100.0 | 100.0 |